PB2311: EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINI B COMBINED WITH CHEMOTHERAPY FOR 17 CASES OF RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

Detalles Bibliográficos
Autores principales: Chen, Qingfeng, Qiu, Yanyan, Qiu, Chenxi, Fu, Haiying, Liu, Tingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429539/
http://dx.doi.org/10.1097/01.HS9.0000975968.56373.2e
_version_ 1785090740012974080
author Chen, Qingfeng
Qiu, Yanyan
Qiu, Chenxi
Fu, Haiying
Liu, Tingbo
author_facet Chen, Qingfeng
Qiu, Yanyan
Qiu, Chenxi
Fu, Haiying
Liu, Tingbo
author_sort Chen, Qingfeng
collection PubMed
description
format Online
Article
Text
id pubmed-10429539
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104295392023-08-17 PB2311: EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINI B COMBINED WITH CHEMOTHERAPY FOR 17 CASES OF RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA Chen, Qingfeng Qiu, Yanyan Qiu, Chenxi Fu, Haiying Liu, Tingbo Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429539/ http://dx.doi.org/10.1097/01.HS9.0000975968.56373.2e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Chen, Qingfeng
Qiu, Yanyan
Qiu, Chenxi
Fu, Haiying
Liu, Tingbo
PB2311: EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINI B COMBINED WITH CHEMOTHERAPY FOR 17 CASES OF RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
title PB2311: EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINI B COMBINED WITH CHEMOTHERAPY FOR 17 CASES OF RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
title_full PB2311: EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINI B COMBINED WITH CHEMOTHERAPY FOR 17 CASES OF RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
title_fullStr PB2311: EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINI B COMBINED WITH CHEMOTHERAPY FOR 17 CASES OF RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
title_full_unstemmed PB2311: EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINI B COMBINED WITH CHEMOTHERAPY FOR 17 CASES OF RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
title_short PB2311: EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINI B COMBINED WITH CHEMOTHERAPY FOR 17 CASES OF RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
title_sort pb2311: efficacy evaluation and safety analysis of zanubrutini b combined with chemotherapy for 17 cases of relapsed refractory diffuse large b-cell lymphoma
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429539/
http://dx.doi.org/10.1097/01.HS9.0000975968.56373.2e
work_keys_str_mv AT chenqingfeng pb2311efficacyevaluationandsafetyanalysisofzanubrutinibcombinedwithchemotherapyfor17casesofrelapsedrefractorydiffuselargebcelllymphoma
AT qiuyanyan pb2311efficacyevaluationandsafetyanalysisofzanubrutinibcombinedwithchemotherapyfor17casesofrelapsedrefractorydiffuselargebcelllymphoma
AT qiuchenxi pb2311efficacyevaluationandsafetyanalysisofzanubrutinibcombinedwithchemotherapyfor17casesofrelapsedrefractorydiffuselargebcelllymphoma
AT fuhaiying pb2311efficacyevaluationandsafetyanalysisofzanubrutinibcombinedwithchemotherapyfor17casesofrelapsedrefractorydiffuselargebcelllymphoma
AT liutingbo pb2311efficacyevaluationandsafetyanalysisofzanubrutinibcombinedwithchemotherapyfor17casesofrelapsedrefractorydiffuselargebcelllymphoma

Ejemplares similares